UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes

Stroke (1970), 2009-04, Vol.40 (4), p.1405-1409

2009

Volltextzugriff (PDF)

Aldosterone induces a vascular inflammatory phenotype in the rat heart

American journal of physiology. Heart and circulatory physiology, 2002-11, Vol.283 (5), p.H1802-H1810

2002

Volltextzugriff (PDF)

Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart Failure

Circulation research, 2003-07, Vol.93 (1), p.69-76

2003

Volltextzugriff (PDF)

Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

Atherosclerosis, 2009-06, Vol.204 (2), p.515-520

2009

Volltextzugriff (PDF)

High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

The New England journal of medicine, 2006-08, Vol.355 (6), p.549-559

2006

Volltextzugriff (PDF)

A Distinctive Role for the Yersinia Protein Kinase: Actin Binding, Kinase Activation, and Cytoskeleton Disruption

Proceedings of the National Academy of Sciences - PNAS, 2000-08, Vol.97 (17), p.9431-9436

2000

Volltextzugriff (PDF)

Effects of Intense Low-Density Lipoprotein Cholesterol Reduction in Patients With Stroke or Transient Ischemic Attack : The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial

Stroke (1970), 2007-12, Vol.38 (12), p.3198-3204

2007

Volltextzugriff (PDF)

Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: A large database analysis of managed care plans in the United States

Clinical therapeutics, 2008, Vol.30 (1), p.195-205

2008

Volltextzugriff (PDF)

Effect of a selective aldosterone receptor antagonist in myocardial infarction

American journal of physiology. Heart and circulatory physiology, 2001-08, Vol.281 (2), p.H647-H654

2001

Volltextzugriff (PDF)

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

Kidney international, 2003-05, Vol.63 (5), p.1791-1800

2003

Volltextzugriff (PDF)

Catalytic Mechanism of the Phospholipase D Superfamily Proceeds Via a Covalent Phosphohistidine Intermediate

Proceedings of the National Academy of Sciences - PNAS, 1998-08, Vol.95 (16), p.9202-9207

1998

Volltextzugriff (PDF)

To replicate or not to replicate? Insights and interpretations from a randomized trial duplication initiative

Journal of comparative effectiveness research, 2021-09, Vol.10 (13), p.953-956

2021

Volltextzugriff (PDF)

Role of Yersinia Murine Toxin in Survival of Yersinia pestis in the Midgut of the Flea Vector

Science (American Association for the Advancement of Science), 2002-04, Vol.296 (5568), p.733-735

2002

Volltextzugriff (PDF)

Inhibition of the Mitogen-Activated Protein Kinase Kinase Superfamily by a Yersinia Effector

Science (American Association for the Advancement of Science), 1999-09, Vol.285 (5435), p.1920-1923

1999

Volltextzugriff (PDF)

Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure

Circulation (New York, N.Y.), 2002-12, Vol.106 (23), p.2967-2972

2002

Volltextzugriff (PDF)

Progression to type 2 diabetes, healthcare utilization, and cost among pre-diabetic patients with or without comorbid hypertension

Current medical research and opinion, 2011-04, Vol.27 (4), p.809-819

2011

Volltextzugriff (PDF)

Substitution of Asparagine for Arginine 347 of Recombinant Factor Xa Markedly Reduces Factor Va Binding

Biochemistry (Easton), 2000-03, Vol.39 (11), p.2861-2867

2000

Volltextzugriff (PDF)

Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study

Current medical research and opinion, 2008-07, Vol.24 (7), p.1987-2000

2008

Volltextzugriff (PDF)

The role of the factor X activation peptide: a deletion mutagenesis approach

Thrombosis and haemostasis, 2002-11, Vol.88 (5), p.756-762

2002

Volltextzugriff (PDF)

Lessons Learned From a Survey of the Diagnosis and Treatment Journeys of Postmenopausal Women With Hypertension

The journal of clinical hypertension (Greenwich, Conn.), 2013-08, Vol.15 (8), p.532-541

2013

Volltextzugriff (PDF)

Aldosterone target organ protection by eplerenone

Molecular and cellular endocrinology, 2004-03, Vol.217 (1), p.229-238

2004

Volltextzugriff (PDF)

Structural, functional, and molecular characterization of the SHHF model of heart failure

American journal of physiology. Heart and circulatory physiology, 2002-11, Vol.283 (5), p.H1775-H1784

2002

Volltextzugriff (PDF)

Inhibition of p38 mitogen-activated protein kinase protects the heart against cardiac remodeling in mice with heart failure resulting from myocardial infarction

Journal of cardiac failure, 2005-02, Vol.11 (1), p.74-81

2005

Volltextzugriff (PDF)

Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone

Mini reviews in medicinal chemistry, 2005-08, Vol.5 (8), p.709-718

2005

Volltextzugriff (PDF)

Definition of a Factor Va Binding Site in Factor Xa

The Journal of biological chemistry, 2001-02, Vol.276 (7), p.5123-5128

2001

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(93)
Buchkapitel
(1)

Sprache

Englisch
(94)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(61)
Humans
(43)
Animals
(24)
Male
(24)
Biological And Medical Sciences
(23)
Female
(20)
Medical Sciences
(19)
Middle Aged
(14)
Cardiovascular System & Cardiology
(13)
Mice
(12)
Neurosciences & Neurology
(11)
Aged
(10)
Clinical Neurology
(10)
Peripheral Vascular Disease
(10)
Adult
(9)
Biochemistry & Molecular Biology
(9)
Cardiac & Cardiovascular Systems
(9)
Immunology
(9)
Spironolactone - Analogs & Derivatives
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes

Aldosterone induces a vascular inflammatory phenotype in the rat heart

Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart Failure

Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

A Distinctive Role for the Yersinia Protein Kinase: Actin Binding, Kinase Activation, and Cytoskeleton Disruption

Effects of Intense Low-Density Lipoprotein Cholesterol Reduction in Patients With Stroke or Transient Ischemic Attack : The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial

Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: A large database analysis of managed care plans in the United States

Effect of a selective aldosterone receptor antagonist in myocardial infarction

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

Catalytic Mechanism of the Phospholipase D Superfamily Proceeds Via a Covalent Phosphohistidine Intermediate

To replicate or not to replicate? Insights and interpretations from a randomized trial duplication initiative

Role of Yersinia Murine Toxin in Survival of Yersinia pestis in the Midgut of the Flea Vector

Inhibition of the Mitogen-Activated Protein Kinase Kinase Superfamily by a Yersinia Effector

Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure

Progression to type 2 diabetes, healthcare utilization, and cost among pre-diabetic patients with or without comorbid hypertension

Substitution of Asparagine for Arginine 347 of Recombinant Factor Xa Markedly Reduces Factor Va Binding

Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study

The role of the factor X activation peptide: a deletion mutagenesis approach

Lessons Learned From a Survey of the Diagnosis and Treatment Journeys of Postmenopausal Women With Hypertension

Aldosterone target organ protection by eplerenone

Structural, functional, and molecular characterization of the SHHF model of heart failure

Inhibition of p38 mitogen-activated protein kinase protects the heart against cardiac remodeling in mice with heart failure resulting from myocardial infarction

Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone

Definition of a Factor Va Binding Site in Factor Xa

Suchergebnisse filtern